Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: BG Medicine, Caprotec, and More

Premium

BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO.

Abdalian most recently was VP and CFO at Knome, and he has been CEO at Pelias Technologies and CFO at Molecular Insight Pharmaceutical Group and Emisphere Technologies.


Caprotec Bioanalytics has appointed Jonathan Turner to be CEO and managing director. Turner will take over the CEO spot from company founder Hubert Koester, who will continue to work with the company as acting chief scientific officer and chairman of the scientific advisory board.

Turner formerly was senior vice president at XL Techgroup, a technology developer and equity firm, and he held senior management posts at Boehringer Ingelheim, AstraZeneca, and Schering.


Aushon Biosystems this week appointed Bill Williams vice president of sales.

Williams was previously founder and owner of the life sciences market research firm Web Prospects. Before that he was US national sales manager for Ciphergen Biosystems.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.